Peter Alping

Single-cell transcriptome landscape of circulating CD4+ T cell populations in autoimmune diseases

Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies